English  |  正體中文  |  简体中文  |  2826152  
???header.visitor??? :  31818883    ???header.onlineuser??? :  1177
???header.sponsordeclaration???
 
臺灣學術機構典藏系統 (Taiwan Academic Institutional Repository, TAIR)
???ui.leftmenu.abouttair???

???ui.leftmenu.bartitle???

???index.news???

???ui.leftmenu.copyrighttitle???

???ui.leftmenu.link???

"pei jer chen"???jsp.browse.items-by-author.description???

???jsp.browse.items-by-author.back???
???jsp.browse.items-by-author.order1??? ???jsp.browse.items-by-author.order2???

Showing items 611-635 of 883  (36 Page(s) Totally)
<< < 20 21 22 23 24 25 26 27 28 29 > >>
View [10|25|50] records per page

Institution Date Title Author
臺大學術典藏 2021-07-03T03:33:40Z Real-world effectiveness and safety of paritaprevir/ritonavir, ombitasvir, and dasabuvir with or without ribavirin for patients with chronic hepatitis C virus genotype 1b infection in Taiwan Liu C.-H.; Liu C.-J.; Su T.-H.; Yang H.-C.; Hong C.-M.; Tseng T.-C.; PEI-JER CHEN; Chen D.-S.; Kao J.-H.
臺大學術典藏 2021-07-03T03:33:40Z A research agenda for curing chronic hepatitis B virus infection Alter H.; Block T.; Brown N.; Brownstein A.; Brosgart C.; Chang K.-M.; PEI-JER CHEN; Chisari F.V.; Cohen C.; El-Serag H.; Feld J.; Gish R.; Glenn J.; Greten T.; Guo H.; Guo J.-T.; Hoshida Y.; Hu J.; Kowdley K.V.; Li W.; Liang J.; Locarnini S.; Lok A.S.; Mason W.; McMahon B.; Mehta A.; Perrillo R.; Revill P.; Rice C.M.; Rinaudo J.; Schinazi R.; Seeger C.; Shetty K.; Tavis J.; Zoulim F.
臺大學術典藏 2021-07-03T03:33:40Z Targeting histone deacetylase 4/ubiquitin-conjugating enzyme 9 impairs DNA repair for radiosensitization of hepatocellular carcinoma cells in mice Tsai C.-L.; Liu W.-L.; Hsu F.-M.; Yang P.-S.; Yen R.-F.; Tzen K.-Y.; Cheng A.-L.; PEI-JER CHEN; Cheng J.C.-H.
臺大學術典藏 2021-07-03T03:33:39Z Distinct Relapse Rates and Risk Predictors after Discontinuing Tenofovir and Entecavir Therapy Su T.-H.; Yang H.-C.; Tseng T.-C.; Liou J.-M.; Liu C.-H.; Chen C.-L.; PEI-JER CHEN; Chen D.-S.; Liu C.-J.; Kao J.-H.
臺大學術典藏 2021-07-03T03:33:39Z Efficacy of Ledipasvir and Sofosbuvir Treatment of HCV Infection in Patients Coinfected With HBV Liu C.-J.; Chuang W.-L.; Sheen I.-S.; Wang H.-Y.; Chen C.-Y.; Tseng K.-C.; Chang T.-T.; Massetto B.; Yang J.C.; Yun C.; Knox S.J.; Osinusi A.; Camus G.; Jiang D.; Brainard D.M.; McHutchison J.G.; Hu T.-H.; Hsu Y.-C.; Lo G.-H.; Chu C.-J.; Chen J.-J.; Peng C.-Y.; Chien R.-N.; PEI-JER CHEN
臺大學術典藏 2021-07-03T03:33:38Z Generic velpatasvir plus sofosbuvir for hepatitis C virus infection in patients with or without human immunodeficiency virus coinfection Liu C.-H.; Sun H.-Y.; Liu C.-J.; Sheng W.-H.; Hsieh S.-M.; Lo Y.-C.; Liu W.-C.; Su T.-H.; Yang H.-C.; Hong C.-M.; Tseng T.-C.; PEI-JER CHEN; Chen D.-S.; Hung C.-C.; Kao J.-H.
臺大學術典藏 2021-07-03T03:33:38Z Fibrosis-4 index predicts cirrhosis risk and liver-related mortality in 2075 patients with chronic HBV infection Tseng T.-C.; Liu C.-J.; Su T.-H.; Yang W.-T.; Chen C.-L.; Yang H.-C.; Kuo S.F.-T.; Liu C.-H.; PEI-JER CHEN; Chen D.-S.; Kao J.-H.
臺大學術典藏 2021-07-03T03:33:38Z Boceprevir-based triple therapy to rescue HCV genotype 1/HBV dually infected patients refractory to peginterferon plus ribavirin combination therapy in Taiwan Hsieh M.-H.; Yeh M.-L.; Su T.-H.; Liu T.-W.; Huang C.-F.; Huang C.-I.; Wang S.-C.; Huang J.-F.; Dai C.-Y.; Kao J.-H.; Chuang W.-L.; PEI-JER CHEN; Liu C.-J.; Yu M.-L.
臺大學術典藏 2021-07-03T03:33:37Z The unique antibody suppresses HBV viremia and reduces hepatocarcinogenesis in HBV-transgenic mice Kang X.-Z.; Guo X.-R.; Chen B.-B.; Zhang T.-Y.; Yuan Q.; PEI-JER CHEN; Zhang J.; Xia N.-S.
臺大學術典藏 2021-07-03T03:33:37Z Acoustic radiation force impulse US imaging: Liver stiffness in patients with chronic hepatitis B with and without antiviral therapy Su T.-H.; Liao C.-H.; Liu C.-H.; Huang K.-W.; Tseng T.-C.; Yang H.-C.; Liu C.-J.; PEI-JER CHEN; Chen D.-S.; Kao J.-H.
臺大學術典藏 2021-07-03T03:33:37Z Vaccine-induced antigen-specific regulatory T cells attenuate the antiviral immunity against acute influenza virus infection Lin P.-H.; Wong W.-I.; Wang Y.-L.; Hsieh M.-P.; Lu C.-W.; Liang C.-Y.; Jui S.-H.; Wu F.-Y.; PEI-JER CHEN; Yang H.-C.
臺大學術典藏 2021-07-03T03:33:36Z Quantification of HBV core antibodies may help predict HBV reactivation in patients with lymphoma and resolved HBV infection Yang H.-C.; Tsou H.-H.; Pei S.-N.; Chang C.-S.; Chen J.-H.; Yao M.; Lin S.-J.; Lin J.; Yuan Q.; Xia N.; Liu T.-W.; PEI-JER CHEN; Cheng A.-L.; Hsu C.; Taiwan Cooperative Oncology Group
臺大學術典藏 2021-07-03T03:33:36Z Generic sofosbuvir-based interferon-free direct acting antiviral agents for patients with chronic hepatitis C virus infection: a real-world multicenter observational study Liu C.-H.; Huang Y.-J.; Yang S.-S.; Chang C.-H.; Yang S.-S.; Sun H.-Y.; Liu C.-J.; Liu W.-C.; Su T.-H.; Yang H.-C.; Hong C.-M.; Tseng T.-C.; PEI-JER CHEN; Chen D.-S.; Hung C.-C.; Kao J.-H.
臺大學術典藏 2021-07-03T03:33:35Z Level of Hepatitis B (HB) Core Antibody Associates With Seroclearance of HBV DNA and HB Surface Antigen in HB e Antigen-Seronegative Patients Hu H.-H.;Liu J.;Chang C.-L.;Jen C.-L.;Lee M.-H.;Lu S.-N.;Wang L.-Y.;Quan Y.;Xia N.-S.;Chen C.-J.;Pei-Jer Chen;Yang H.-I.; Hu H.-H.; Liu J.; Chang C.-L.; Jen C.-L.; Lee M.-H.; Lu S.-N.; Wang L.-Y.; Quan Y.; Xia N.-S.; Chen C.-J.; PEI-JER CHEN; Yang H.-I.
臺大學術典藏 2021-07-03T03:33:35Z Taiwan consensus statement on the management of chronic hepatitis B Chien R.-N.;Kao J.-H.;Peng C.-Y.;Chen C.-H.;Liu C.-J.;Huang Y.-H.;Hu T.-H.;Yang H.-I.;Lu S.-N.;Ni Y.-H.;Chuang W.-L.;Lee C.-M.;Wu J.-C.;Pei-Jer Chen;Liaw Y.-F.; Chien R.-N.; Kao J.-H.; Peng C.-Y.; Chen C.-H.; Liu C.-J.; Huang Y.-H.; Hu T.-H.; Yang H.-I.; Lu S.-N.; Ni Y.-H.; Chuang W.-L.; Lee C.-M.; Wu J.-C.; PEI-JER CHEN; Liaw Y.-F.
臺大學術典藏 2021-07-03T03:33:35Z Evaluation of SH-SAW Biosensor in Whole Blood Kano K.; Huang Y.-Q.; Kogai T.; Huang Y.-T.; Yatsuda H.; PEI-JER CHEN; Liu S.-H.
臺大學術典藏 2021-07-03T03:33:35Z Real-world effectiveness and safety of sofosbuvir and ledipasvir with or without ribavirin for patients with hepatitis C virus genotype 1 infection in Taiwan Liu C.-H.; Liu C.-J.; Su T.-H.; Yang H.-C.; Hong C.-M.; Tseng T.-C.; PEI-JER CHEN; Chen D.-S.; Kao J.-H.
臺大學術典藏 2021-07-03T03:33:34Z Early antiviral therapy reduces the risk of lymphoma in patients with chronic hepatitis C infection Su T.-H.;Liu C.-J.;Tseng T.-C.;Chou S.-W.;Liu C.-H.;Yang H.-C.;Wu S.-J.;Pei-Jer Chen;Chen D.-S.;Chen C.-L.;Kao J.-H.; Su T.-H.; Liu C.-J.; Tseng T.-C.; Chou S.-W.; Liu C.-H.; Yang H.-C.; Wu S.-J.; PEI-JER CHEN; Chen D.-S.; Chen C.-L.; Kao J.-H.
臺大學術典藏 2021-07-03T03:33:34Z Efficacy and safety of 12 weeks of daclatasvir, asunaprevir plus ribavirin for HCV genotype-1b infection without NS5A resistance-associated substitutions Yu M.-L.;Hung C.-H.;Huang Y.-H.;Peng C.-Y.;Lin C.-Y.;Cheng P.-N.;Chien R.-N.;Hsu S.-J.;Liu C.-H.;Huang C.-F.;Su C.-W.;Huang J.-F.;Liu C.-J.;Kao J.-H.;Chuang W.-L.;Pei-Jer Chen;Chen D.-S.; Yu M.-L.; Hung C.-H.; Huang Y.-H.; Peng C.-Y.; Lin C.-Y.; Cheng P.-N.; Chien R.-N.; Hsu S.-J.; Liu C.-H.; Huang C.-F.; Su C.-W.; Huang J.-F.; Liu C.-J.; Kao J.-H.; Chuang W.-L.; PEI-JER CHEN; Chen D.-S.
臺大學術典藏 2021-07-03T03:33:34Z Profile and value of FIB-4 in patients with dual chronic hepatitis C and B Liu C.-J.;Tseng T.-C.;Yang W.-T.;Su T.-H.;Yang H.-C.;Liu C.-H.;Pei-Jer Chen;Chen D.-S.;Kao J.-H.; Liu C.-J.; Tseng T.-C.; Yang W.-T.; Su T.-H.; Yang H.-C.; Liu C.-H.; PEI-JER CHEN; Chen D.-S.; Kao J.-H.
臺大學術典藏 2021-07-03T03:33:34Z Cell and Animal Models for Studying Hepatitis B Virus Infection and Drug Development Hu J.;Lin Y.-Y.;Pei-Jer Chen;Watashi K.;Wakita T.; Hu J.; Lin Y.-Y.; PEI-JER CHEN; Watashi K.; Wakita T.
臺大學術典藏 2021-07-03T03:33:33Z Chronic hepatitis B is associated with an increased risk of B-cell non-Hodgkin's lymphoma and multiple myeloma Su T.-H.;Liu C.-J.;Tseng T.-C.;Chou S.-W.;Liu C.-H.;Yang H.-C.;Wu S.-J.;Pei-Jer Chen;Chen D.-S.;Chen C.-L.;Kao J.-H.; Su T.-H.; Liu C.-J.; Tseng T.-C.; Chou S.-W.; Liu C.-H.; Yang H.-C.; Wu S.-J.; PEI-JER CHEN; Chen D.-S.; Chen C.-L.; Kao J.-H.
臺大學術典藏 2021-07-03T03:33:33Z Androgen Receptor Enhances Hepatic Telomerase Reverse Transcriptase Gene Transcription After Hepatitis B Virus Integration or Point Mutation in Promoter Region Li C.-L.;Li C.-Y.;Lin Y.-Y.;Ho M.-C.;Chen D.-S.;Pei-Jer Chen;Yeh S.-H.; Li C.-L.; Li C.-Y.; Lin Y.-Y.; Ho M.-C.; Chen D.-S.; PEI-JER CHEN; Yeh S.-H.
臺大學術典藏 2021-07-03T03:33:33Z Smoking and Hepatitis B Virus–Related Hepatocellular Carcinoma Risk: The Mediating Roles of Viral Load and Alanine Aminotransferase Wang Y.-H.;Chuang Y.-H.;Wu C.-F.;Jan M.-C.;Wu W.-J.;Lin C.-L.;Liu C.-J.;Yang Y.-C.;Pei-Jer Chen;Lin S.-M.;Tsai M.-H.;Huang Y.-W.;Yu M.-W.; Wang Y.-H.; Chuang Y.-H.; Wu C.-F.; Jan M.-C.; Wu W.-J.; Lin C.-L.; Liu C.-J.; Yang Y.-C.; PEI-JER CHEN; Lin S.-M.; Tsai M.-H.; Huang Y.-W.; Yu M.-W.
臺大學術典藏 2021-07-03T03:33:32Z Lymphocyte Antigen 6 Complex, Locus C+ Monocytes and Kupffer Cells Orchestrate Liver Immune Responses Against Hepatitis B Virus in Mice Wu L.-L.;Peng W.-H.;Wu H.-L.;Miaw S.-C.;Yeh S.-H.;Yang H.-C.;Liao P.-H.;Lin J.-S.;Chen Y.-R.;Hong Y.-T.;Wang H.-Y.;Pei-Jer Chen;Chen D.-S.; Wu L.-L.; Peng W.-H.; Wu H.-L.; Miaw S.-C.; Yeh S.-H.; Yang H.-C.; Liao P.-H.; Lin J.-S.; Chen Y.-R.; Hong Y.-T.; Wang H.-Y.; PEI-JER CHEN; Chen D.-S.

Showing items 611-635 of 883  (36 Page(s) Totally)
<< < 20 21 22 23 24 25 26 27 28 29 > >>
View [10|25|50] records per page